WINDLAS BIOTECH
Quarterly Results Analysis [Dec2023]
WINDLAS BIOTECH Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹162 Cr | ₹153 Cr | ₹145 Cr | ₹141 Cr | ₹120 Cr | ₹133 Cr | ₹120 Cr | ₹122 Cr |
Expenses | ₹142 Cr | ₹134 Cr | ₹128 Cr | ₹124 Cr | ₹106 Cr | ₹117 Cr | ₹106 Cr | ₹108 Cr |
Operating Income | ₹20 Cr | ₹19 Cr | ₹17 Cr | ₹16 Cr | ₹14 Cr | ₹16 Cr | ₹14 Cr | ₹14 Cr |
Other Income | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
Profit Before Tax | ₹20 Cr | ₹18 Cr | ₹16 Cr | ₹15 Cr | ₹13 Cr | ₹16 Cr | ₹14 Cr | ₹14 Cr |
Profit After Tax | ₹15 Cr | ₹14 Cr | ₹12 Cr | ₹11 Cr | ₹9 Cr | ₹12 Cr | ₹10 Cr | ₹15 Cr |
EPS | ₹7.26 | ₹6.75 | ₹5.80 | ₹5.47 | ₹4.29 | ₹5.60 | ₹4.50 | ₹6.79 |
Industry Peers & Returns | 1W | 1M | 1Y |
WINDLAS BIOTECH | 2.3% | -5% | 120.3% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
WINDLAS BIOTECH Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 6.25 % |
Y-o-Y | 35.51 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹162 Cr | 6.25 | |
Sep2023 | ₹153 Cr | 5.45 | |
Jun2023 | ₹145 Cr | 2.89 | |
Mar2023 | ₹141 Cr | 17.55 | |
Dec2022 | ₹120 Cr | -9.81 | |
Sep2022 | ₹133 Cr | 10.67 | |
Jun2022 | ₹120 Cr | -1.80 | |
Mar2022 | ₹122 Cr | - |
WINDLAS BIOTECH Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 8.83 % |
Y-o-Y | 45.80 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹20 Cr | 8.83 | |
Sep2023 | ₹19 Cr | 9.01 | |
Jun2023 | ₹17 Cr | 4.28 | |
Mar2023 | ₹16 Cr | 17.86 | |
Dec2022 | ₹14 Cr | -13.06 | |
Sep2022 | ₹16 Cr | 16.34 | |
Jun2022 | ₹14 Cr | -0.35 | |
Mar2022 | ₹14 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 2.45 % |
Y-o-Y | 7.64 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 12.54% | 2.45 | |
Sep2023 | 12.24% | 3.38 | |
Jun2023 | 11.84% | 1.37 | |
Mar2023 | 11.68% | 0.26 | |
Dec2022 | 11.65% | -3.64 | |
Sep2022 | 12.09% | 5.13 | |
Jun2022 | 11.5% | 1.50 | |
Mar2022 | 11.33% | - |
WINDLAS BIOTECH Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 7.60 % |
Y-o-Y | 64.32 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹15 Cr | 7.60 | |
Sep2023 | ₹14 Cr | 16.30 | |
Jun2023 | ₹12 Cr | 5.43 | |
Mar2023 | ₹11 Cr | 24.55 | |
Dec2022 | ₹9 Cr | -24.65 | |
Sep2022 | ₹12 Cr | 24.43 | |
Jun2022 | ₹10 Cr | -33.73 | |
Mar2022 | ₹15 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 1.31 % |
Y-o-Y | 21.22 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 9.31 % | 1.31 | |
Sep2023 | 9.19 % | 10.32 | |
Jun2023 | 8.33 % | 2.46 | |
Mar2023 | 8.13 % | 5.86 | |
Dec2022 | 7.68 % | -16.43 | |
Sep2022 | 9.19 % | 12.48 | |
Jun2022 | 8.17 % | -32.54 | |
Mar2022 | 12.11 % | - |
WINDLAS BIOTECH Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 7.56 % |
Y-o-Y | 69.23 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹7.26 | 7.56 | |
Sep2023 | ₹6.75 | 16.38 | |
Jun2023 | ₹5.8 | 6.03 | |
Mar2023 | ₹5.47 | 27.51 | |
Dec2022 | ₹4.29 | -23.39 | |
Sep2022 | ₹5.6 | 24.44 | |
Jun2022 | ₹4.5 | -33.73 | |
Mar2022 | ₹6.79 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD